Latest Equities News

Nanollose Limited has secured $2.1 million in strategic funding to accelerate the commercialisation of its sustainable fibres and soilless growth technologies, marking a pivotal shift from R&D to market-ready products.

Sunshine Metals Limited reported a $179,000 net cash outflow from operating activities in the December 2024 quarter, with cash reserves standing at $1.5 million. The company is actively exploring funding options to sustain its exploration programs amid fluctuating cash flows.

Lendlease has agreed to sell Capella Capital for $235 million and completed the $516 million sale of its US Military Housing business, reinforcing its strategy to streamline operations and reduce funding needs.

Lefroy Exploration Limited reported a modest net cash decrease in the December quarter, ending with $3.24 million in cash reserves and nearly four quarters of funding available. The company continues to invest heavily in exploration activities despite operating cash outflows.

Simonds Group has agreed to acquire Dennis Family Homes for $10 million, significantly expanding its residential construction footprint and product portfolio across Victoria and New South Wales. The acquisition is expected to be earnings accretive from the first quarter of FY26.

Simonds Group Limited has agreed to acquire Dennis Family Homes for an estimated $10 million, significantly broadening its product portfolio and market presence in Victoria and New South Wales. The deal is expected to boost revenue by $200 million in FY26 and be earnings accretive by Q1 FY26.

AUCyber has received a new acquisition proposal from Interactive Pty Ltd but maintains its recommendation for shareholders to accept 5GN’s revised and unconditional offer.

Emerald Resources NL has reported record quarterly gold production at its Okvau Gold Mine, alongside significant resource expansions in Cambodia and Australia, positioning the company for robust growth.

Gas2Grid navigates regulatory headwinds in Australia by pursuing new petroleum ventures in the Philippines while contesting a significant legal claim in France. The company’s ASX suspension persists as it seeks to restore compliance through fresh contracts.

Telix Pharmaceuticals has completed a strategic acquisition of ImaginAb, gaining next-generation therapeutic assets and a novel biologics platform to expand its oncology pipeline and R&D capabilities.

Canterbury Resources reports significant drilling success at its Briggs copper-molybdenum project, with an updated resource estimate and scoping study underway, while exploration at Bismarck yields no economic mineralisation.

Vitrafy Life Sciences reports strong Q2 FY2025 progress, marked by a successful $35 million IPO, promising validation results in animal and human health, and strategic expansion into North America.